Tuesday, March 19, 2013

• Fidelity manager says healthcare law, cuts will hit biotechat Reuters (Tue, Mar 19)
• Fidelity manager says healthcare law, cuts will hit biotechReuters (Tue, Mar 19)

Monday, March 18, 2013

• Should Incyte Investors Be Panicked?at Motley Fool (Mon, Mar 18)
• Analysts: Salesforce.com Seeing Opportunity and 4 New Opinions Investors Must Know Nowat Wall St. Cheat Sheet (Mon, Mar 18)

Friday, March 15, 2013

• Gilead Sciences Inc (GILD): Today's Featured Drugs Laggardat TheStreet (Fri, Mar 15)
• Chimerix names chief development officerat bizjournals.com (Fri, Mar 15)
• 3 Stocks Pushing The Health Care Sector Lowerat TheStreet (Fri, Mar 15)
• The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbertat Seeking Alpha (Fri, Mar 15)

Thursday, March 14, 2013

• Vertex: The Sun Sets On Incivek, Rises On Its CF Franchiseat Seeking Alpha (Thu, Mar 14)
• Analysts: EBay Won’t be Hurt by MasterCard Rules and 4 New Opinions Investors Must Read Nowat Wall St. Cheat Sheet (Thu, Mar 14)

Wednesday, March 13, 2013

• Achillion: A Tiny Biopharmaceutical Stock With Tremendous Potentialat Seeking Alpha (Wed, Mar 13)
• Immunokinase Drug Candidates: $12B in Value Creation and Countingat Forbes (Wed, Mar 13)
• Gilead Hits 52-Week HighZacks (Wed, Mar 13)
• The Zacks Analyst Blog Highlights: Aetna, Humana, UnitedHealth Group, WellPoint and Gilead SciencesZacks (Wed, Mar 13)

Tuesday, March 12, 2013

• Gilead Reaches New 52-Week High (GILD)at TheStreet (Tue, Mar 12)
• Encouraging Data Presented by GileadZacks (Tue, Mar 12)
• Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD)at TheStreet (Tue, Mar 12)

Monday, March 11, 2013

• Biotech Watch-List: Medicine Co., Alkermes, Celgeneat Investor's Business Daily (Mon, Mar 11)
• Gilead Puts Biotech ETFs in FocusZacks (Mon, Mar 11)
• Early Movers: DKS, NOK, JPM & Moreat CNBC (Mon, Mar 11)
• Trader bets against collapse in GileadoptionMONSTER (Mon, Mar 11)

Sunday, March 10, 2013

• Gilead drug reduces chest pain episodes in diabetics -studyat Reuters (Sun, Mar 10)
• Gilead’s Ranexa® Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 DiabetesBusiness Wire (Sun, Mar 10)

Saturday, March 9, 2013

• This Week in Biotechat Motley Fool (Sat, Mar 9)

Friday, March 8, 2013

• [$$] Pfizer Stops Developing Hepatitis C Drugat The Wall Street Journal (Fri, Mar 8)

Add GILD News to My Yahoo!